CABA

CABALETTA BIO INC

CABA·12674W109·US·Common Stock·Healthcare - Biotechnology-13D/G

CABA (CABALETTA BIO INC) is held by 68 institutional investors as of Q1 2026. Largest holders: JENNISON ASSOCIATES LLC ($24.1M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($23.8M), MILLENNIUM MANAGEMENT LLC ($15.9M). Net institutional sentiment: Mixed.

68
Holders
Avg rating(12 Elite)
$136.7M
Total Value
63% (75)
Fund Consensus
40 buying - 24 selling
CABASmart Money Verdict
View all
Held by 68 funds
12 elite
Who's Trading
ActivistPRUDENTIAL FINANCIAL INCPRUDENTIAL FINANCIAL INC11.4%Jun 5, 2026
ActivistJennison Associates LLCJennison Associates LLC11.4%Jun 4, 2026
ActivistCACormorant Asset Management, LP9.0%May 15, 2026
ActivistMillennium Management LLCMillennium Management LLC5.3%Feb 18, 2026
ActivistAIAlyeska Investment Group, L.P.4.7%Feb 17, 2026
ActivistTRT. Rowe Price Investment Management, Inc.10.2%Feb 17, 2026
InsiderNSNichtberger StevenBuy $101KJan 21, 2026
InsiderSMSimon MarkBuy $25KJan 21, 2026
InsiderBGBinder GwendolynBuy $25KJan 21, 2026
InsiderTSTomasello ShawnBuy $50KJan 21, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9M(+0.7%)$24.1M0.0%-35.11%
29
Unchanged
8.8M$23.8M0.0%-48.67%
0
Increased
5.9M(+115.7%)$15.9M0.0%+5.02%
45
New
4M$10.8M0.0%-8.62%
38
Increased
2.5M(+35.8%)$6.7M0.0%+6.78%
35
Increased
2.4M(+1.9%)$6.4M0.0%+31.07%
28
Increased
2.2M(+127.3%)$5.9M0.0%+1.13%
44
Increased
2M(+33.8%)$5.5M0.0%+17.28%
35
Increased
1.9M(+484.2%)$5.2M0.0%-3.33%
44
Increased
1.4M(+4.8%)$3.8M0.0%-15.71%
28
Unchanged
1.3M$3.4M0.0%+54.86%
0
Increased
1.1M(+4.4%)$3M0.0%-54.91%
28
Increased
783,220(+81.9%)$2.1M0.0%+11.60%
40
New
765,000$2.1M0.0%-8.62%
36
Increased
740,648(+63.9%)$2M0.0%+15.18%
38
Unchanged
756,637$1.9M0.0%+38.14%
0
Increased
606,664(+46.0%)$1.6M0.0%-2.06%
35
New
570,191$1.5M0.0%-8.62%
35
Increased
469,978(+10.5%)$1.3M0.0%-72.16%
19
Decreased
442,277(-59.6%)$1.2M0.0%-51.07%
0

Showing 1-20 of 75

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used